企業プロフィール
PerkinElmer 株価・ニュース・カタリスト
- ティッカー:
- RVTY
- 取引所:
- NYSE
- セクター:
- MedTech
- 所在地:
- United States
株価パフォーマンス
116.17 USD (-0.57%)
終値
最終更新: 2026年8月17日
11.2B USD
時価総額
株価変動の要因
As of Aug 17, 2026, RVTY closed down 0.57% at $116.17. No new same-company headline was identified in the current news window.
企業概要
事業概要
Revvity is a life sciences tools and diagnostics company with exposure to discovery, reproductive health, applied markets, and clinical testing. The company evolved from PerkinElmer into a more focused platform around testing and life sciences infrastructure.
所在地とセクター分類
Headquartered in the United States and listed on NYSE, Revvity has a global footprint in life sciences tools and diagnostics. It sits in research and diagnostic infrastructure, not therapeutics.
ビジネスモデルの特徴
The company earns revenue from instruments, consumables, software, and diagnostic workflows. Investors focus on lab demand, prenatal and reproductive testing, and the health of research spending across its core markets.
バイオ業界での位置付け
Revvity sits in the biotech tools layer and benefits from the broader life sciences spending cycle. It is less binary than a drug stock, but it remains important because research and diagnostics budgets drive demand.
今後のカタリスト
- Revvity’s catalysts are diagnostics demand, pharma-tools recovery, and any signs that the research-market backdrop is improving. This matters because it helps show whether the company can turn its current footprint into a cleaner earnings profile. Better execution here can matter even before a new product or trial headline lands.
最近のニュース
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。